Photodynamic Treatment as Part of Oral Healthcare on Persons With Sjögren's Syndrome

NAActive, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 24, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Sjogren SyndromeXerostomia
Interventions
DEVICE

Lumoral treatment

"Lumoral® Treatment devices are handed over to study participants on the first visit. The treatment is performed first at the clinic under supervision by the researchers. Treatment is then repeated at home twice a week for 12 weeks.~The treatment is started by dissolving one 7 mg Lumorinse® oral tablet in 30 ml amount of pure water. The tablet dissolves in water in one minute, after which the mouthwash is poured into the mouth and swished for 60 seconds. The indocyanine green in the mouthwash adheres to the plaque surface in the teeth and gum line. The mouthwash is then spat out and the mouthpiece of the Lumoral® Treatment device is inserted into the mouth and a light is activated. After 10 minutes, the device turns itself off, after which the mouthpiece is removed from the mouth. Normal oral hygiene routines will then be performed."

Trial Locations (1)

Unknown

Metropolia University of applied sciences, Helsinki

All Listed Sponsors
collaborator

Metropolia University of Applied Sciences

OTHER

lead

Koite Health Oy

INDUSTRY

NCT06877546 - Photodynamic Treatment as Part of Oral Healthcare on Persons With Sjögren's Syndrome | Biotech Hunter | Biotech Hunter